ZS Pharma Inc (ZSPH) Generating Strong Interest from Top Money Managers

Because ZS Pharma Inc (NASDAQ:ZSPH) has witnessed declining sentiment from hedge fund managers, it’s safe to say that there was a specific group of hedgies who sold off their positions entirely last quarter. It’s worth mentioning that Israel Englander’s Millennium Management cut the biggest stake of the 700 funds followed by Insider Monkey, totaling about $28.2 million in stock, and Christopher James’ Partner Fund Management was right behind this move, as the fund dropped about $23.6 million worth of shares. These transactions are interesting, as aggregate hedge fund interest dropped by 2 funds last quarter.

Let’s also examine hedge fund activity in other stocks – not necessarily in the same industry as ZS Pharma Inc (NASDAQ:ZSPH) but similarly valued. We will take a look at National Penn Bancshares (NASDAQ:NPBC), Retail Opportunity Investments Corp (NASDAQ:ROIC), Simpson Manufacturing Co, Inc. (NYSE:SSD), and Alliance Resource Partners, L.P. (NASDAQ:ARLP). This group of stocks’ market values are closest to ZSPH’s market value.

As you can see these stocks had an average of 11 hedge funds with bullish positions and the average amount invested in these stocks was $122 million. That figure was $458 million in ZSPH’s case. National Penn Bancshares (NASDAQ:NPBC) is the most popular stock in this table. On the other hand Alliance Resource Partners, L.P. (NASDAQ:ARLP) is the least popular one with only 5 bullish hedge fund positions. Compared to these stocks ZS Pharma Inc (NASDAQ:ZSPH) is more popular among hedge funds. Considering that hedge funds are fond of this stock in relation to its market cap peers and have a lot more capital invested in it, it may be a good idea to analyze it in detail and potentially include it in your portfolio.